Key result
Drugs promoting alterations of Ca2+ handling may be pro-arrhythmogenic without QT interval change at rest, highlighting the need to investigate Ca2+-dependent mechanisms in drug safety evaluation.
Drug safety evaluations should include investigations into Ca2+-dependent arrhythmias, as these can occur without resting QT interval prolongation.
Answers are grounded in this paper and cite their sources.
May warrant Ca2+ handling assessment in drug safety beyond QT monitoring; leaves open whether current protocols adequately predict arrhythmia risk.
BACKGROUND: Voltage-gated ion channels are the main providers of drug-induced delayed repolarization and, therefore, first line targets in cardiac safety assessments. OBJECTIVES/METHODS: We review mechanisms of drug-induced ventricular arrhythmias that may be associated with sudden cardiac death. We focus on Ca(2+)-dependent mechanisms with drug safety concerns. RESULTS: Early afterdepolarizations occur during abnormally prolonged action potential repolarization. QT interval measurement is commonly used to assess the proarrhythmic risk of a drug. However, delayed afterdepolarizations are triggered by intracellular Ca(2+) overload and/or abnormal spontaneous openings of ryanodine receptors in diastole. A drug promoting alterations of Ca(2+) handling may be pro-arrhythmogenic without QT interval change at rest. CONCLUSION: Ca(2+)-dependent arrhythmia should be investigation matter in drug safety evaluation.
No takes yet. Share an insight, caveat, or question.
Pasquié et al. (2009) conducted a review in Drug-induced ventricular arrhythmias. Ca2+-dependent arrhythmia investigation vs. QT interval measurement alone was evaluated. Drugs promoting alterations of Ca2+ handling may be pro-arrhythmogenic without QT interval change at rest, highlighting the need to investigate Ca2+-dependent mechanisms in drug safety evaluation.
Synapse has enriched 10 related papers. Consider them for comparative context: